Water Island Capital LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Water Island Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Nov 14, 2024	SELL	$38.96 - $42.75 $854,665 - $937,806	-21,937 Reduced 2.78%	766,933 $31.4 Million
Q2 2024 Aug 14, 2024	SELL	$38.96 - $42.75 $854,665 - $937,806	-21,937 Reduced 2.78%	766,933 $31.4 Million
Q1 2024 Nov 14, 2024	BUY	$40.88 - $43.27 $8.21 Million - $8.69 Million	200,770 Added 34.14%	788,870 $33.3 Million
Q1 2024 May 15, 2024	BUY	$40.88 - $43.27 $8.21 Million - $8.69 Million	200,770 Added 34.14%	788,870 $33.3 Million
Q4 2023 Nov 14, 2024	BUY	$20.27 - $42.44 $11.9 Million - $25 Million	588,100 New	588,100 $24.9 Million
Q4 2023 Feb 13, 2024	BUY	$20.27 - $42.44 $11.9 Million - $25 Million	588,100 New	588,100 $24.9 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Water Island Capital LLC with notifications on news.